Home > Insider Trading > Filing (0001144204-14-008800)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1335103	Protea Biosciences Group Inc.	NONE	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1529511	P Leonard Harris	955 Hartman Run Road Morgantown WV 26507		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-30	166,667	$250,001.00	1,773,657	No	4	P	Direct
Common Stock	Acquisiton	2013-07-23	387,334	$193,667.00	2,160,991	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2006-06-07	100,000	$80,000.00	100,000	$0.80
Common Stock	Stock Option	Acquisiton	2010-09-17	100,000	$150,000.00	100,000	$1.50
Common Stock	Warrant	Acquisiton	2010-10-18	100,000	$200,000.00	100,000	$2.00
Common Stock	Warrant	Acquisiton	2011-09-30	83,333	$0.00	83,333	$2.00
Common Stock	Stock Option	Acquisiton	2013-03-22	218,750	$120,313.00	218,750	$0.55
Common Stock	Convertible Note	Disposition	2013-07-23	387,334	$193,667.00	0	$0.50
Common Stock	Warrant	Acquisiton	2013-07-23	290,501	$319,551.00	290,501	$1.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
678,334	2006-06-07	2016-06-07	No	4	A	Direct
778,334	2010-09-01	2017-09-01	No	4	A	Direct
878,334	2010-10-18	2015-10-18	No	4	P	Direct
961,667	2011-09-30	2016-09-30	No	4	P	Direct
1,180,417	2013-03-22	2023-03-22	No	4	A	Direct
1,047,083	2013-07-23	2013-07-23	No	4	C	Direct
1,337,584	2018-07-23	2018-07-23	No	4	P	Direct

Footnotes

On September 30, 2011, Leo Harris (the "Reporting Person") acquired 166,667 shares of common stock and warrants to purchase 83,333 shares of common stock for an aggregate purchase price of $25,000.
On June 30, 2013, pursuant to the terms and conditions of a Conversion Agreement, dated June 18, 2013 (the "Conversion Agreement") the Reporting Person converted the Notes (as defined below) into 387,334 shares of common stock, in connection with the conversion of convertible promissory notes (each a "Note" and collectively, the "Notes") issued to the Reporting Person in an aggregate amount equal to $193,667.14 including principal and interest.The Notes accrue simple interest at the rate of 10% per annum and were initially convertible into shares of common stock at a conversion rate of $2.00 per share at any time prior to payment in full of the principal and interest due under the Notes. On March 22, 2013, the board of directors of the Company agreed to reduce the conversion rate of the Notes to $0.50 per share. The Notes were converted into shares of common stock of the Company in accordance with the Conversion Agreement on June 30, 2013.
Pursuant to the Conversion Agreement, upon conversion of the Notes, the Company agreed to issue a warrant to purchase 75% of the number of shares into which the Notes are convertible.
Represents shares vested as of February 10, 2014.
Reflects the expiration of previously reported warrants to purchase 133,334 shares of common stock.